Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

2
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
2
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

2
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
2
Bacterial Toxins01:12

Bacterial Toxins

108
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
108
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

4
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
4
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

61
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
61

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of Gastroenterology.

Gut·2026
Same author

Towards a Standard Protocol for Fecal Microbiota Transplantation in Irritable Bowel Syndrome.

Journal of neurogastroenterology and motility·2026
Same author

Metagenomic insights into the urban-rural variation of antimicrobial resistance and pathogen reservoirs in untreated wastewater from central India.

Frontiers in microbiology·2026
Same author

NETosis in ischemic stroke: Mechanisms, implications, and therapeutic prospects.

Pharmacology & therapeutics·2026
Same author

Distinct T and innate-like lymphocyte reprogramming following lyophilized fecal microbiota transplantation in recurrent <i>C. difficile</i> infection.

Gut microbes·2026
Same author

Untargeted Metabolomics Identifies Faecal Filtrate-Derived Metabolites That Disrupt <i>Clostridioides difficile</i> Metabolism and Confer Gut Barrier Cytoprotection.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Apr 18, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.5K

New perspectives in Clostridium difficile disease pathogenesis.

Tanya M Monaghan1

  • 1Biomedical Research Unit, NIHR Nottingham Digestive Diseases Centre, Nottingham University Hospitals NHS Trust, Derby Road, Nottingham NG7 2UH, UK.

Infectious Disease Clinics of North America
|January 10, 2015
PubMed
Summary
This summary is machine-generated.

Clostridium difficile infection causes illness ranging from mild to life-threatening. Its development involves bacterial toxins, gut microbe imbalance, and host inflammation, highlighting key factors in disease.

Keywords:
Clostridium difficileHost responseMicrobiotaSporeVirulence factors

More Related Videos

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.5K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

40.5K

Related Experiment Videos

Last Updated: Apr 18, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.5K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.5K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

40.5K

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Clostridium difficile causes a range of illnesses, from asymptomatic carriage to severe colitis.
  • Pathogenesis is understood as multifactorial, involving bacterial toxins, gut dysbiosis, and host inflammation.

Purpose of the Study:

  • To summarize recent findings on C. difficile virulence mechanisms.
  • To elucidate the roles of host immunity, microbiota, and metabolome in disease.

Main Methods:

  • Review of current literature on C. difficile pathogenesis.
  • Analysis of cellular and molecular mechanisms of bacterial virulence.
  • Examination of host-pathogen interactions.

Main Results:

  • Identified key bacterial factors contributing to C. difficile virulence.
  • Highlighted the significant impact of gut microbial dysbiosis.
  • Underscored the role of host inflammatory responses in disease severity.

Conclusions:

  • C. difficile pathogenesis is complex, involving bacterial and host factors.
  • Understanding these mechanisms is crucial for developing targeted therapies.
  • Further research into the host immune response and metabolome is warranted.